Prior studies suggest that low-risk ST-segment-elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention can be considered for early discharge. We describe the implementation of an STEMI risk score to decrease cost while maintaining optimal patient outcomes.
T
here is increasing pressure to improve the value of healthcare, as defined by optimal patient health outcomes at lower cost.
1 Common, highcost healthcare conditions may offer significant opportunities to achieve this goal. Care of patients with ST-segment-elevation myocardial infarction (STEMI) represents one such condition, with >250 000 patients experiencing a STEMI in the United States annually, 2 at an estimated cost of ≈$20 000 a case. 3 Although STEMI is a life-threatening cardiovascular emergency, much of the associated clinical risk is mitigated by successful primary percutaneous coronary intervention (PCI). 4 As such, some patients may not require a high acuity of care or lengthy hospitalization after successful PCI. Prior studies have demonstrated the feasibility of identifying low-risk patients who may be safely triaged to lower acuity telemetry care and early discharge. [5] [6] [7] [8] The implications of risk-guided patient triage after primary PCI on costs of care and long-term patient outcomes have not been described.
We first sought to determine the potential impact of risk-guided STEMI care on healthcare value using a retrospective comparison of actual costs with estimated costs if low-risk patients were triaged to telemetry and discharge within 48 hours. We then prospectively evaluated the impact of an electronic medical record (EMR)-integrated risk calculator to support the identification and standardized care of low-risk patients after successful primary PCI for STEMI.
METHODS
The data, analytic methods, and study materials will be made available to other researchers for purposes of reproducing the results or replicating the procedure. Contact the authors to obtain these materials.
We designed the project in 3 phases: (1) retrospective risk score validation, (2) EMR tool design and integration, and (3) prospective application of the EMR risk tool in providing triage and discharge guidance to providers at the point of care. The project was undertaken at the Minneapolis Heart Institute at Abbott Northwestern Hospital, which supports a large regional STEMI program that uses a standardized protocol and integrated transfer system for primary PCI from 31 hospitals and 10 clinics throughout Minnesota and Wisconsin. [9] [10] [11] In the first phase of the study, we retrospectively applied the Zwolle Risk Score to all patients presenting to our regional STEMI system between January 2009 and December 2011. This risk score incorporates 6 clinical and angiographic variables (age, ischemic time, Killip class, number of vessels with coronary artery disease, if the involved vessel led to an anterior infarction, and Thrombolysis in Myocardial Infarction flow after PCI), with each variable being assigned a weighted point value. Scores of 0 to 3 are categorized as low risk for 30-day mortality or post-discharge out of hospital cardiac arrest while scores ≥4 are considered high risk 5 (Table 1) . Clinical and administrative data, including baseline demographic information, cardiac risk profiles, and pre-PCI clinical presentation (cardiac arrest, cardiogenic shock, and Killip class), were collected. Clinical outcomes, including post-PCI triage location (telemetry bed versus intensive care), hospital length of stay (LOS), ejection fraction and in-hospital, 30-day and 1-year mortalities, were assessed. We also assessed post-PCI major adverse cardiovascular events (MACE), including stroke, myocardial infarction, and death at either 30 days or 1 year, as well as rates of periprocedural complications (red blood cell transfusion, bleeding within 72 hours, development of cardiogenic shock, development of new heart failure, and new need for dialysis) as per National Cardiovascular Data Registry definitions. Costs of care, measured as median total variable cost, were obtained from comprehensive data within Allina Health's Enterprise Data Warehouse. The warehouse, which integrates data from hospitals and clinics, is a single shared electronic data repository, which supports the comprehensive analytic need to identify, measure, and improve clinical quality, financial outcomes, and reporting.
In phase 2, the Minneapolis Heart Institute at Abbott Northwestern Hospital System's Level 1 Myocardial Infarction-STEMI Committee reviewed the retrospective data and developed an implementation strategy for risk-guided STEMI care. The committee determined that out of hospital cardiac arrest, while not in the original score, should constitute a high-risk factor and that patients with this clinical presentation should be admitted to the cardiac intensive care unit (CICU), regardless of traditional Zwolle Risk Score. The modified Zwolle Risk Score, incorporating out of hospital cardiac arrest as an automatic high-risk feature, was added to the EMR at Minneapolis Heart Institute at Abbott Northwestern Hospital, enabling risk-based guidance in the postprocedural acuity of care and discharge targets after primary PCI for STEMI. The score was calculated on the completion of primary PCI while the patient was still in the catheterization laboratory. Patients with STEMI who did not undergo PCI or died in the catheterization laboratory were excluded. Patients with a low-risk score were recommended to be transferred to a telemetry floor and be
WHAT IS KNOWN
• ST-segment-elevation myocardial infarction is a life threatening and expensive medical condition; however, much of the risk is mitigated by prompt revascularization.
• Risk models exist to be able to predict which patients can bypass the intensive care unit after revascularization and be targeted for early discharge from the hospital.
WHAT THE STUDY ADDS
• We demonstrate the feasibility of implementation of an evidence-based risk stratification tool into the electronic medical record for triaging patients after revascularization for ST-segment-elevation myocardial infarction.
• Use of an electronic medical record-based Zwolle Risk Calculator is safe and results in shorter lengths of stays and lower hospital costs for patients with ST-segment-elevation myocardial infarction.
discharged within 48 hours. High-risk patients were recommended to be transferred to the CICU, without recommendation made on timing of discharge. Although the decision support tool recommended triage to either telemetry or the CICU, the final decision on admission location and discharge date was at the discretion of the primary provider. Completion of the risk score and adherence to the protocol by each physician were tracked and incorporated into providers' quality metrics, which was linked to an annual quality component of their salary. The program was launched at Minneapolis Heart Institute at Abbott Northwestern Hospital in July 2013.
In phase 3, after development and implementation of an EMR-based risk calculator and protocol for low-risk STEMI patients, we prospectively evaluated the impact on eligible patients with STEMI between July 2013 and December 2014. The same data measures collected for the retrospective cohort in phase 1 were prospectively collected after implementation of the risk calculator.
Descriptive statistics are displayed as means and SDs for continuous variables; number and percentage with characteristic are given for categorical variables. When continuous variables had skewed distributions (cost data and LOS), data are summarized with medians and 25th and 75th percentiles. Table 2 ). After PCI, low-risk patients had a significantly higher median ejection fraction (50.7±12.8% versus 43.0±12.3%; P<0.00; Table 2 ) and lower rates of procedural complications (any complication 6.5% versus 17.1%; P<0.001), including postprocedural cardiogenic shock (0.3% versus 5.1%; P<0.001), need for red blood cell transfusion (2.3% versus 11.0%; P<0.001), and new need for dialysis (0% versus 1.7%; P=0.027; Figure 1 ). These patients also experienced lower rates of composite MACE at 30 days (0.9% versus 13.8%; P<0.001) and 1 year (5.0% versus 17.8%; P<0.001), as well as in-hospital (0% versus 11.9%; P<0.001), 30-day (0.2% versus 12.9%; P<0.001), and 1-year mortality (3.9% versus 16.4%; P<0.001; Table 3 ).
Evaluation of Risk-Guided STEMI Care
After implementation of the modified Zwolle Risk Calculator into the EMR, 549 patients were prospectively assessed, of which 462 met inclusion criteria. Of these, 286 (61.9%) were categorized as low risk and 176 (38.1%) high risk. Providers followed the recommend- The left 2 columns contain the clinical variables and associated weighted points for each. The Zwolle Risk Score is calculated by summing the points total for each variable. The relative risk of death at 30 days based on a given score are located in the right 2 columns. Low-risk patients are defined by a score of ≤3. ed protocol in 75% of the cases, with 177 (61.9%) of the low-risk patients admitted to telemetry and 168 (95.5%) of the high-risk patients admitted to the CICU ( Figure 2) . As in the retrospective cohort, compared with high-risk patients, low-risk patients were younger (61.8±13.4 versus 66.3±12.3; P<0.001) and had lower rates of pre-PCI cardiac arrest (0% versus 33.5%; P<0.001) and cardiogenic shock (0% versus 11.9%; P<0.001) although the groups were otherwise similar ( Table 2) .
Comparison of low risk, on-protocol (transferred to telemetry) versus off-protocol (transferred to CICU) Preprocedure clinical characteristics, postprocedure ejection fraction, length of stay, complications, and mortality for retrospectively studied high-risk (n=427) vs. low-risk (n=540) STEMI patients, prospectively studied high-risk (n=176) vs. low-risk (n=286) STEMI patients, and prospectively studied on-protocol low-risk (n=177) vs. off-protocol low-risk (n=109) STEMI patients. LOS indicates length of stay; MACE, major adverse cardiovascular event; MI, myocardial infarction; PCI, primary percutaneous coronary intervention; and STEMI, ST-segment-elevation myocardial infarction. patients demonstrated no difference in baseline demographic or clinical characteristics, although after PCI low-risk on-protocol patients did have a higher median ejection fraction (55.6%±9.7 versus 51.3%±11.5; P<0.001; Table 2 ) and overall lower composite procedural complication rate compared with those treated off-protocol (4.3% versus 14.9%; P=0.003), including bleeding at 72 hours (2.5% versus 8.9%; P=0.018) although need for blood transfusion did not meet statistical significance (1.2% versus 3.0%; P=0.31; Figure 3) . There was no difference between low risk onand off-protocol patients for in-hospital, 30-day, or 1-year mortality or in 30-day or 1-year MACE (Table 2; Figure 4 ).
There was only 1 in-hospital death in the low-risk cohort. A patient initially admitted to the CICU with a stroke who subsequently experienced an in-hospital STEMI therefore a low-risk off-protocol. After PCI, the patient returned to the CICU but was ultimately placed on palliative care and died. At 30 days, there were 2 additional deaths in the low-risk off-protocol group. One patient experienced an in-stent thrombosis 7 days after PCI, with subsequent death and another had an unknown cause of death, 22 days post-STEMI. In the low risk on-protocol group at 30 days, there was only 1 death in a patient who died of a type A dissection 26 days post-STEMI.
Regarding resource use, the median LOS was shorter for low-risk patients both on-and off-protocol compared with high-risk patients, with low risk on-protocol patients having the shortest LOS (median and [25th, 75th percentiles], low-risk on-protocol: 2 [1, 2]; low-risk off-protocol: 2 [2, 3] ; high-risk: 3 [2, 6] ; P<0.001 between all groups; Table 2 ). The distribution of LOS in the 3 groups is shown in Figure I in the Data Supplement. A total of 54 (30.5%) low-risk patients were discharged earlier than 48 hours with no mortality at 1 year. Significant differences in median total hospital costs were also noted between the 3 groups, with the lowest cost also noted in the low risk on-protocol patients (median and [25th, Table 3 ).
Effect of Protocol Adherence on Low-Risk Patients
In the retrospective cohort, no low-risk patients were triaged to telemetry. There was no in hospital mortality in either cohorts and no significant differences in clinical characteristics, mortality, or MACE at 1 year. Both mean and median LOS were significantly shorter in the low-risk on-protocol prospective cohort compared with the low-risk retrospective cohort (mean 2.1±2.5 versus 3.5±4.4; P<0.001; Table I in the Data Supplement). Comparison of complications and mortality for high-risk (n=427) and low-risk (n=540), retrospectively studied ST-segment-elevation myocardial infarction (STEMI) patients. Any complication is defined as a composite of red blood cell (RBC) transfusion, cardiogenic shock, congestive heart failure (CHF), and new need for dialysis. Mortality was measured in-hospital and at 30 d and 1 y. 
DISCUSSION
We describe a unique care innovation, initially using retrospective application of a risk tool to assess potential implications of risk-guided STEMI care, followed by integration of the risk tool in the EMR to support triage and discharge guidance to providers after primary PCI, and finally the prospective evaluation of risk-guided STEMI care on patient outcomes and costs of care. This process provided assurance that application of risk-guided care would safely reduce costs, and therefore successful application at the point of care would improve the value of STEMI care.
Prior work on the feasibility of use of the Zwolle Risk Score has demonstrated its ability to safely reduce LOS; however, these studies were small, retrospective, and outside the United States, limiting their generalizability. One Spanish study examined 276 patients with the Zwolle Risk Score, however, only did so retrospectively. 6 A prospective study from the same country looked only at low-risk patients, of which just 54 were targeted for early discharge, with no assessment of effect on cost. 12 The Safe-Depart Trial studied prospective implementation of the Zwolle Score in a Canadian hospital, but only 54 patients were enrolled, Comparison of complications and mortality for high-risk (n=176), on-protocol low-risk (n=177), and off-protocol low-risk (n=109), prospectively studied ST-segment-elevation myocardial infarction patients.Any complication is defined as a composite of red blood cell (RBC) transfusion, cardiogenic shock, congestive heart failure (CHF), and new need for dialysis. Mortality was measured in-hospital and at 30 d and 1 y. of whom just 27 had the risk score applied to their care. 8 Larger studies of early discharge after STEMI have been performed but with much larger variations from primary literature-based protocols and without cost analyses. 7 The study that initially developed the Zwolle Risk Score 5 did perform a prospective analysis of the model; however, this was only for validation, not as an assessment of feasibility of clinical use of the score, because the results were not used to change patient care. Furthermore, only 58% of patients in the validation cohort received a stent, with the remainder undergoing only angioplasty, the standard of care at that time. The cost-effectiveness analysis in the original analysis was done based on cost estimates rather than true changes in cost. We describe the successful integration of the Zwolle Risk Score into a large regional STEMI system rather than as a stand-alone research protocol, allowing for generalizability to real-world clinical settings. In addition, our study demonstrates true, rather than estimated cost savings associated with this value-based intervention.
When developing systems to improve the value of care, healthcare providers and leaders must first ensure that changes either maintain or improve the safety and quality of care they provide. To ensure both safety and provider buy in to risk-guided STEMI care, we emphasized efforts to exclude potentially high-risk patients from a low-risk pathway. This included addition of patients with out of hospital cardiac arrest to the Zwolle Risk Score. Our prospective analysis of this modified Zwolle Risk Score demonstrated several important findings. First, based on both retrospective and prospective analysis, low-risk STEMI patients are common, representing >50% of eligible individuals in our study. Second, it validated the modified score's ability to accurately characterize risk post-PCI, with only 1 in-hospital death in the low-risk cohort, occurring in an off-protocol patient, already admitted to the hospital for a different, high-risk diagnosis, stroke.
Total protocol adherence (sending low-risk patients to telemetry and high-risk patients to the CICU) was 75% but was only 62% for low-risk patients. Although exact reasons for protocol deviation were not recorded, bleeding represents an apparent contributing factor to low adherence, with higher complication rates for low-risk off-protocol patients triaged to the CICU driven largely by bleeding events. Clinical factors not captured by the risk calculator also likely contributed to protocol deviation, highlighted by the only in-hospital death in the prospective low-risk group attributed to an inpatient STEMI patient, already admitted with a stroke. These factors suggest that further refinements of the risk-tool may be possible, incorporating other clinical factors identified by providers in making treatment decisions. This also suggests that clinical expertise will remain important as providers apply clinical judgment in the application of risk-based care guidance. Furthermore, full adoption of risk-guided treatment decisions may not reflect optimal care and the potential for negative consequences of adherence to clinical decision support requires attention. Despite this, provider confidence in the protocol's ability to improve quality continued to grow after the study period, with CICU triage for patients with STEMI declining to 33.0% by 2017.
This finding also highlights the risk of using process measures as surrogates for outcomes measures. Standardized processes, while helpful, do not always capture the complexity of a given patient nor do they necessarily correlate with improved outcomes.
1 Of greater importance than provider adherence in this study is the improved clinical efficiency and low complication rate, indicative of improved value to both the health system and the patient. Given this and the results our study achieved, the Level 1 Myocardial Infarction STEMI Committee at our institution set a protocol adherence goal for providers at 75% to allow for appropriate clinical deviation from the protocol while still encouraging high value care decision making.
Increasingly, changes in care must demonstrate an ability to improve value, either achieving quality improvement that was not previously recognized or decreasing cost while maintaining or improving on current quality outcomes. Comparison of low-risk patients treated on-versus off-protocol demonstrates that adherence to triage recommendation could save >$2300 per patient. Based on the initial protocol adherence rate of 62% for the low-risk patients, extrapolation to the entire Allina system (700 total STEMI patients per year) would achieve savings of $623 844 annually. Protocol adherence of 85% in the low-risk patients across the system would save $855 270 a year. Ongoing work to track Kaplan-Meier survival analysis comparing high-risk (n=176), on-protocol low-risk (n=177), and off-protocol low-risk (n=109) patients in the prospective cohort.
physician level protocol adherence and evaluation of variance is vital to both achieving this goal and understanding what other factors contribute to the differences between low-risk patients on-and off-protocol. Such future work will drive improvements in both protocol implementation and patient safety, honing our understanding of what currently unaccounted for factors lead to adverse events.
Imperative to achieving this goal and monitoring future tests of change is a robust data tracking mechanism. Our shared EMR and Enterprise Data Warehouse provided accurate, real-time clinical, financial, and outcomes data, which served as the foundation for the retrospective analysis and provided a platform to deploy the prospective standardized early discharge protocol. Without this tool, successfully identifying low-risk STE-MI patients, improving clinical efficiency and realizing reduced healthcare costs would have required a vastly increased amount of time and staff hours. To address these and similar challenges, all healthcare systems should invest in the personnel and infrastructure required to adequately understand and monitor their own data.
Although this current initiative focuses on post-PCI care for STEMI, numerous other risk calculators and models exist across the spectrum of cardiovascular disease. [13] [14] [15] Within acute myocardial infarction, expansion of risk models to the triage of patients presenting with non-STEMI for early discharge may be able to realize similar reductions in LOS and total costs, without compromising quality of care or patient outcomes. Similarly, as percutaneous approaches to structural and valvular heart disease increase, risk-based care delivery strategies may help to achieve higher value care. The current work serves as a model for these types of future endeavors to reduce costs of care while maintaining optimal patient outcomes.
There are limitations to our study, including its single-center design, which may limit generalizability. We also used just 1 risk score (Zwolle) while others, such as the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications Score, have also been described for the purpose of identifying patients for early discharge. 13 The prior validation of the Zwolle Risk Score and the ubiquitous nature of the EMR across the health system, however, provide the framework for this model to be adopted in other institutions. Our institution also integrates quality metrics into providers' salary, which likely contributed to the rapid early uptake of the protocol, which may not occur at institutions without similar mechanisms in place. The use of total variable costs may also limit generalizability of realized cost savings as differences in direct and indirect costs across institutions may vary. Furthermore, the large number of patients with STEMI treated by our regional STEMI program allowed large cost savings to be realized quickly, a component which may take longer in smaller networks.
The rapidly evolving healthcare landscape and demand for efficient, high-quality cardiovascular treatment necessitates the use of appropriate risk stratification for the triage of patients with STEMI. This work demonstrates the potential value of the Zwolle Risk Score in STEMI to reduce costs while maintaining high quality of care and lays the framework for future work in other patient populations and clinical conditions.
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